Global Custom Synthesis and Radiolabeling Market Growth (Status and Outlook) 2024-2030

Global Custom Synthesis and Radiolabeling Market Growth (Status and Outlook) 2024-2030

Custom synthesis and radiolabeling services involve the tailored production and incorporation of radioactive isotopes into specific molecules for a wide range of applications in medical, research, industrial, agricultural, and environmental fields. These services include the design, synthesis, and radiolabeling of compounds to meet unique client requirements, ensuring precise and effective tracking, imaging, and analysis of biological and chemical processes.

The global Custom Synthesis and Radiolabeling market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Custom Synthesis and Radiolabeling Industry Forecast” looks at past sales and reviews total world Custom Synthesis and Radiolabeling sales in 2022, providing a comprehensive analysis by region and market sector of projected Custom Synthesis and Radiolabeling sales for 2023 through 2029. With Custom Synthesis and Radiolabeling sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Synthesis and Radiolabeling industry.

This Insight Report provides a comprehensive analysis of the global Custom Synthesis and Radiolabeling landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Synthesis and Radiolabeling portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Synthesis and Radiolabeling market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Synthesis and Radiolabeling and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Synthesis and Radiolabeling.

United States market for Custom Synthesis and Radiolabeling is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Custom Synthesis and Radiolabeling is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Custom Synthesis and Radiolabeling is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Custom Synthesis and Radiolabeling players cover Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Synthesis and Radiolabeling market by product type, application, key players and key regions and countries.

Segmentation by Type:
C-14
H-3
I-125
Others

Segmentation by Application:
Drug Discovery
Medical
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
C-14
H-3
I-125
Others

Segmentation by Application:
Drug Discovery
Medical
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Eurofins Scientific
PerkinElmer
Sekisui Medical
Eckert & Ziegler
Labcorp
XenoTech (BioIVT)
Quotient Sciences
Gifford Bioscience
ITM Radiopharma
Almac Group
Accelera
Novandi Chemistry
AptoChem
HMR
AM Chemicals
PolyPeptide Group
NovoPro Bioscience
Institute of Isotopes
Nuvisan
Revvity
Necsa
Fluorizon
Edinburgh Pharmaceutical Processes
Chelatec
Pharmaron
Medicilon
JOINN Laboratories
Frontage
Abace Biotechnology
Beijing Atom High-Tech
Wuxi Beita Pharmatech
Beijing North Institute of Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.